DS Healthcare Group Expands Its Distribution Channels In $43 Billion Brazilian Beauty Market

Pompano Beach, Aug. 5, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ:DSKX), a leading developer ofpersonal care products, today announced it has expanded thedistribution of its product lines into Brazil's CSB Drogaria whichoperates two retail pharmacy chains, Drogasmil and Farmalife, whichtogether have 85 retail store locations. The stores are primarilylocated in the Rio de Janeiro metropolitan area. CSB Drogaria isowned by Profarma, a leader in the distribution to pharmacies,distributing 18 million units per month, through 31,000 salesoutlets, covering 93% of the consumer market for pharmaceuticalproducts in Brazil.

DS Healthcare Group is expected to experience rapid salesincreases in Brazil, as itsestablished distribution there grows.

"Our 10 best-selling SKUs which are approved forcommercialization and distribution are currently being sold in theBrazilian market. This includes our leading hair loss products. We plan on receiving further regulatory approvals as salesbegin to accelerate. We are working with a fantastic partner thereand are excited about this new relationship. Based on the successof this pilot program, we expect to continue to expand throughout Profarma's network, oneof the biggest distributors in Brazil. We believe our products havea considerable advantage to anything currently being sold inBrazil," stated DS Healthcare President and CEO Daniel Khesin.

According to Euromonitor, a market research firm, the Brazilianbeauty industry generated $43 billion in sales in 2011, an increase of 19% over the prioryear.

About DS Healthcare Group

DS Healthcare Group Inc. leads in the development anddistribution of topical therapies for personal care, including whatmanagement believes is the world's most effective topical treatmentfor hair loss. Its products are sold through a network of salons,online retailers, specialty retailers and selected departmentstores. Its brands include DS Laboratories ( www.DSLaboratories.com), SigmaSkin (www. ( www.SigmaSkin.com), PolarisResearch Laboratories ( www.PolarisReserachLabs.com),The Pure Guild ( www.ThePureGuild.com) and NutraOrigin ( www.NutraOrigin.com)

Forward-looking statements

Except for statements of historical fact, the matters discussedin this press release are forward-looking and made pursuant to theSafe Harbor provisions of the Private Securities Litigation ReformAct of 1995. "Forward-looking statements" describe futureexpectations, plans, results, or strategies, and are generallypreceded by words such as "future," "plan" or "planned," "expects,"or "projected." These forward-looking statements reflect numerousassumptions and involve a variety of risks and uncertainties, manyof which are beyond the company's control that may cause actualresults to differ materially from stated expectations. These riskfactors include, among others, limited operating history,difficulty in developing and marketing products, intensecompetition, and additional risks factors as discussed in reportsfiled by the company with the Securities and Exchange Commission,which are available at www.sec.gov.

CONTACT: Contact:         Laurel Moody         Corporate Profile         1.646.810.0608